...
首页> 外文期刊>CardioVascular and Interventional Radiology >Use of 120 Kilovolt Tube Potential for Digital Subtraction Angiography and Fluoroscopy in an Image-Intensifier Angiographic System: Decrease of Skin Dose in Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma
【24h】

Use of 120 Kilovolt Tube Potential for Digital Subtraction Angiography and Fluoroscopy in an Image-Intensifier Angiographic System: Decrease of Skin Dose in Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma

机译:在图像增强血管造影系统中使用120千伏管电位进行数字减影血管造影和荧光检查:肝癌经动脉化疗栓塞治疗中皮肤剂量的减少

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In an image-intensifier angiographic system, the tube potential is commonly regulated in ranges from 75 to 90 kV for digital subtraction angiography (DSA) and fluoroscopy in transarterial chemoembolization therapy (TACE) for hepatocellular carcinoma. The purpose of this study was to investigate whether or not a 120-kV tube potential could be used for DSA and fluoroscopy in TACE to decrease the skin dose. Forty-three patients administered TACE were randomly allocated into two groups: TACE was performed using standard-kilovoltage (75- to 90-kV) DSA and fluoroscopy modes (group A; n = 20) or using high-kilovoltage (120-kV) modes (group B; n = 23). The peak skin dose was compared between the groups. One case in group A was excluded from the study because the HCC nodule was not depicted on DSA. The peak skin dose (mGy) for group A was 383.6 ± 176.5 and that for group B was 265.1 ± 145.1. The peak skin dose was decreased by 31% in the 120-kV mode, a statistically significant difference (t-test, p = 0.022). We conclude that the use of 120 kV tube potential for DSA and fluoroscopy may be one option for performing TACE while decreasing the skin dose.
机译:在图像增强型血管造影系统中,对于肝细胞癌,数字减影血管造影(DSA)和荧光透视在经动脉化学栓塞治疗(TACE)中通常将电子管电势调节在75至90 kV之间。这项研究的目的是调查是否可以将120 kV的管电势用于TACE中的DSA和荧光检查以减少皮肤剂量。 43例接受TACE的患者被随机分为两组:使用标准千伏电压(75至90kV)DSA和荧光透视模式(A组; n = 20)或高千伏电压(120 kV)进行TACE模式(B组; n = 23)。比较两组之间的皮肤峰值剂量。由于未在DSA上显示HCC结节,因此将A组中的1例排除在研究之外。 A组的皮肤峰值剂量(mGy)为383.6±176.5,B组的皮肤峰值剂量为265.1±145.1。在120 kV模式下,皮肤峰值剂量降低了31%,具有统计学意义的差异(t检验,p = 0.022)。我们得出的结论是,在DSA和荧光检查中使用120 kV的管电势可能是在减少皮肤剂量的同时进行TACE的一种选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号